公开(公告)号：US20240216513A1

公开(公告)日：2024-07-04

申请号：US18281732

申请日：2022-03-10

Applicant: Novartis AG

Inventor： Claire Adcock ,  Valerie Broennimann ,  Jiashun Cheng ,  Rohit Kumar Duvadie ,  Tanzina Fazal ,  Jinhai Gao ,  Fengfeng Guo ,  Robert Martin Grotzfeld ,  Christina Hebach ,  Gregory John Hollingworth ,  Darryl Brynley Jones ,  Alexei Karpov ,  Jialiang Li ,  Julien Lorber ,  Chester A. Metcalf, III ,  Walter Michael ,  Mark Gabriel Palermo ,  Scott Vaughan Plummer ,  James Harold Roache ,  Martin Sendzik ,  Ranny Mathew Thomas ,  Aimee Richardson Usera ,  Anna Vulpetti ,  Frederic Zecri ,  Liang Zhao ,  Thomas Zoller

IPC: A61K47/54 ,  A61K31/395 ,  A61K47/10 ,  A61P35/00

CPC classification number: A61K47/542 ,  A61K31/395 ,  A61K47/10 ,  A61P35/00

Abstract: Described herein are fatty acid-bifunctional degrader compounds, their various targets, their preparation, pharmaceutical compositions comprising them, and their use in the treatment of conditions, diseases, and disorders mediated by various target proteins.

公开(公告)号：US10947218B2

公开(公告)日：2021-03-16

申请号：US16884666

申请日：2020-05-27

Applicant: NOVARTIS AG

Inventor： Luca Arista ,  Sreehari Babu ,  Jianwei Bian ,  Kai Cui ,  Michael Patrick Dillon ,  Rene Lattmann ,  Jialiang Li ,  Lv Liao ,  Dimitrios Lizos ,  Rita Ramos ,  Nikolaus Johannes Stiefl ,  Thomas Ullrich ,  Peggy Usselmann ,  Xiaoyang Wang ,  Liladhar Murlidhar Waykole ,  Sven Weiler ,  Yubo Zhang ,  Yizong Zhou ,  Tingying Zhu

IPC: A61K31/4427 ,  C07D405/14 ,  C07D401/14 ,  C07D401/10 ,  C07D401/12 ,  C07D409/14 ,  C07D213/82 ,  C07D411/14 ,  C07D491/107 ,  A61P19/00 ,  C07D417/00 ,  C07D413/00 ,  C07D419/00 ,  A61P19/08 ,  C07D413/10 ,  C07D413/12 ,  C07D413/14 ,  C07D491/20

Abstract: The invention relates to a compound of formula (I) in free form or in pharmaceutically acceptable salt form to pharmaceutical compositions comprising said compound and to the use of said compound in the treatment of heterotopic ossification and fibrodysplasia ossificans progressiva.

公开(公告)号：US10710980B2

公开(公告)日：2020-07-14

申请号：US16318250

申请日：2017-07-18

Applicant: NOVARTIS AG

Inventor： Luca Arista ,  Sreehari Babu ,  Jianwei Bian ,  Kai Cui ,  Michael Patrick Dillon ,  Rene Lattmann ,  Jialiang Li ,  Lv Liao ,  Dimitrios Lizos ,  Rita Ramos ,  Nikolaus Johannes Stiefl ,  Thomas Ullrich ,  Peggy Usselmann ,  Xiaoyang Wang ,  Liladhar Murlidhar Waykole ,  Sven Weiler ,  Yubo Zhang ,  Yizong Zhou ,  Tingying Zhu

IPC: C07D405/14 ,  C07D401/14 ,  C07D401/10 ,  C07D401/12 ,  C07D409/14 ,  C07D213/82 ,  C07D411/14 ,  C07D491/107 ,  A61P19/00 ,  C07D417/00 ,  C07D413/00 ,  C07D419/00 ,  A61P19/08 ,  C07D413/10 ,  C07D413/12 ,  C07D413/14 ,  C07D491/20

Abstract: The invention relates to a compound of formula (I) in free form or in pharmaceutically acceptable salt form (I) to pharmaceutical compositions comprising said compound and to the use of said compound in the treatment of heterotopic ossification and fibrodysplasia ossificans progressiva.